We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+10.86%
1 Year Est. Return
+31.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$251M
AUM Growth
+$9.77M
Cap. Flow
-$5.29M
Cap. Flow %
-2.11%
Top 10 Hldgs %
13.15%
Holding
258
New
40
Increased
80
Reduced
24
Closed
99

Sector Composition

Rank Sector Weight
1 Technology 23.99%
2 Healthcare 17.12%
3 Consumer Discretionary 12.37%
4 Communication Services 10.85%
5 Financials 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRVL icon
126
CorVel
CRVL
$3.08B
$1.07M 0.43%
74,145
+6,078
+9% +$80.1K
HSTM icon
127
HealthStream
HSTM
$814M
$1.06M 0.42%
43,814
WAT icon
128
Waters Corp
WAT
$36.4B
$1.05M 0.42%
6,717
ACRS icon
129
Aclaris Therapeutics
ACRS
$750M
$1.03M 0.41%
+34,558
New +$996K
LHCG
130
DELISTED
LHC Group LLC
LHCG
$1.03M 0.41%
19,072
-8,048
-30% -$391K
GILD icon
131
Gilead Sciences
GILD
$162B
$1.02M 0.41%
15,024
-1,474
-9% -$104K
BRK.A icon
132
Berkshire Hathaway Class A
BRK.A
$1.07T
$999K 0.4%
4
KMI icon
133
Kinder Morgan
KMI
$70.6B
$996K 0.4%
45,800
-16,400
-26% -$358K
GNTX icon
134
Gentex
GNTX
$4.88B
$989K 0.39%
46,375
-11,187
-19% -$235K
CLR
135
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$978K 0.39%
21,539
+6,705
+45% +$316K
VEEV icon
136
Veeva Systems
VEEV
$31.6B
$976K 0.39%
+19,026
New +$855K
PBYI icon
137
Puma Biotechnology
PBYI
$407M
$971K 0.39%
+26,105
New +$953K
SJM icon
138
J.M. Smucker
SJM
$12.9B
$964K 0.38%
7,352
-181
-2% -$24.6K
AKAM icon
139
Akamai
AKAM
$16.4B
$955K 0.38%
15,994
MMSI icon
140
Merit Medical Systems
MMSI
$4.54B
$952K 0.38%
32,931
-15,669
-32% -$439K
BBWI icon
141
Bath & Body Works
BBWI
$4.13B
$951K 0.38%
24,974
-1,415
-5% -$63.8K
AR icon
142
Antero Resources
AR
$10.5B
$929K 0.37%
+40,746
New +$998K
BF.B icon
143
Brown-Forman Class B
BF.B
$12.6B
$910K 0.36%
30,784
-922
-3% -$27.4K
HII icon
144
Huntington Ingalls Industries
HII
$11.4B
$910K 0.36%
+4,543
New +$923K
XBIT icon
145
XBiotech
XBIT
$68.9M
$862K 0.34%
+52,289
New +$685K
BRK.B icon
146
Berkshire Hathaway Class B
BRK.B
$1.07T
$848K 0.34%
5,086
PRMW
147
DELISTED
Primo Water Corporation
PRMW
$843K 0.34%
+62,052
New +$853K
ORLY icon
148
O'Reilly Automotive
ORLY
$75.1B
$822K 0.33%
45,720
+8,400
+23% +$152K
NRC icon
149
NRC Health Common Stock
NRC
$479M
$818K 0.33%
41,527
+5,840
+16% +$108K
WBA
150
DELISTED
Walgreens Boots Alliance
WBA
$778K 0.31%
9,373

Similar funds

Capital Impact Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Capital Impact Advisors held 258 positions worth $251M, up 4% from $241M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Capital Impact Advisors's Q1 2017 filing shows 40 new, 80 increased, 24 reduced and 99 closed positions. Its largest new stake was SS&C Technologies: 93,104 shares worth $3.3M. The largest sale was United Therapeutics, an estimated $2.89M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Capital Impact Advisors's largest Q1 2017 buy was SS&C Technologies: 93,104 shares worth $3.3M.
  • Capital Impact Advisors added most to Alphabet (Google) Class A in Q1 2017, an estimated $2.9M increase.
  • Capital Impact Advisors's biggest Q1 2017 reduction was United Therapeutics, cutting an estimated $2.89M.
  • Capital Impact Advisors fully exited Huntsman Corp in Q1 2017, selling an estimated $2.66M.
  • Capital Impact Advisors's ten largest holdings make up 13% of its $251M portfolio in Q1 2017.
  • Capital Impact Advisors opened 40 new positions and closed 99 in Q1 2017.
  • Capital Impact Advisors's portfolio value rose 4% quarter-over-quarter to $251M.

Based on Capital Impact Advisors's 13F filing for Q1 2017, filed 19 Apr 2017.